Status: current, Defined. Date: 31-May 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 103091000036113 | emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 103101000036116 | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + rilpivirine 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | tenofovir + emtricitabine + rilpivirine | false | Inferred relationship | Some | ||
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1521333742 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 1521333742 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has intended active ingredient | rilpivirine | true | Inferred relationship | Some | 1431039746 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has Australian BoSS | rilpivirine | true | Inferred relationship | Some | 1431039746 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has intended active ingredient | tenofovir | false | Inferred relationship | Some | 1837618617 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has Australian BoSS | tenofovir disoproxil fumarate | false | Inferred relationship | Some | 1837618617 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has unit of use | tablet | true | Inferred relationship | Some | 1837618618 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | rilpivirine 25 mg tablet | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet | false | Inferred relationship | Some | ||
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | tenofovir disoproxil + emtricitabine + rilpivirine | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has Australian BoSS | tenofovir disoproxil fumarate | true | Inferred relationship | Some | 1506444894 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | has intended active ingredient | tenofovir disoproxil | true | Inferred relationship | Some | 1506444894 | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eviplera tablet | Is a | True | emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Inferred relationship | Some | |
| tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + rilpivirine 25 mg tablet, 30 | has MPUU | True | emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR